Bempedoic Acid and Statins in Lipid-Lowering Strategy: Which Came First, the Egg or the Chicken?
The goal in cardiovascular prevention is the reduction of morbidity and mortality through the promotion of healthy lifestyles in the general population. The management of modifiable risk factors with pharmacological and non-pharmacological interventions, based on the individual risk is the first str...
Main Authors: | Francesco Natale, Riccardo Molinari, Rosa Franzese, Noemi Mollo, Giovanni Cimmino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Future Pharmacology |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-9879/3/2/24 |
Similar Items
-
Bempedoic Acid: Safety and Efficiacy of a New Lipid-Lowering Agent
by: I. A. Mazerkina, et al.
Published: (2023-09-01) -
From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01) -
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
by: Ulrich Laufs, et al.
Published: (2019-04-01) -
Fibromyalgia and Sedentarism: Which Came First, the Chicken or the Egg?
by: Carmen Daniela Quero-Calero, et al.
Published: (2024-03-01) -
Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015-11-01)